analysis showing a 13q14 deletion is helpful in ruling out the diagnosis of DAM and AMFB; similarly, the detection of HMGA2 rearrangements by means of immunohistochemistry or molecular biology is helpful for the diagnosis of DAM; (iv) if the pathologist is dealing with a tumour exhibiting overlapping morphological features among the different histotypes (especially for CAF, AMFB and MFB) it could be a trivial problem to try to subtype a specific tumour at any cost and the use of the generic term “benign stromal tumour of the lower female genital tract” seems to be appropriate. Here, HMGA2 is linked to neoplasm.